Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27834805 | 0.98 | ALDH1A1 (0.42) | ALDH1A1LMNATSHRHSD17B10NPSR1 | |
| SCHEMBL19687702 | 0.82 | ALDH1A1 (0.44) | ALDH1A1LMNATSHRHSD17B10NPSR1 | |
| SCHEMBL7731153 | 0.81 | ALDH1A1 (0.40) | ALDH1A1LMNATSHRHSD17B10NPSR1 | |
| SCHEMBL1980527 | 0.81 | LMNA (0.41) | ALDH1A1LMNATSHRHSD17B10ALOX15 | |
| SCHEMBL1331989 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRHSD17B10NPSR1 | |
| SCHEMBL9823358 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRHSD17B10NPSR1 | |
| SCHEMBL7262 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNATSHRHSD17B10NPSR1 | |
| SCHEMBL297916 | 0.81 | TSHR (0.59) | ALDH1A1LMNATSHRHSD17B10GAA | |
| SCHEMBL11295643 | 0.81 | TSHR (0.53) | ALDH1A1LMNATSHRHSD17B10NPSR1 | |
| SCHEMBL629560 | 0.78 | TSHR (0.56) | ALDH1A1LMNATSHRHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0354108-B1 | Amino acids and peptides with a modified tyrosine, their preparation and their use as medicines | INST NAT SANTE RECH MED (FR) | 1994-03-09 | — | — | EP | claimed |
| CN-118510877-A | Cleaning composition for pretreatment of metal substrates, method for the production thereof and use thereof | 巴斯夫涂料有限公司 | 2024-08-16 | — | — | CN | disclosed |
| WO-2023131530-A1 | A CLEANING COMPOSITION FOR METAL SUBSTRATES PRETREATMENT AND ITS PREPARATION METHOD AND APPLICATION THEREOF | BASF COATINGS GMBH (DE) | 2023-07-13 | — | — | WO | disclosed |
| US-20170258795-A1 | FUSED PYRIMIDINES AS INHIBITORS OF P97 COMPLEX | CLEAVE THERAPEUTICS, INC. | 2017-09-14 | — | — | US | disclosed |
| US-9545104-B2 | Liquid suspension concentrate formulations containing saflufenacil and glyphosate | BASF SE (DE) | 2017-01-17 | — | — | US | disclosed |
| US-20160329599-A1 | Lithium Secondary Battery Electrolyte and Lithium Secondary Battery Comprising Same | SK INNOVATION CO., LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| US-8741809-B2 | Liquid pyraclostrobin-containing crop protection formulations | BASF SE (DE) | 2014-06-03 | — | — | US | disclosed |
| US-8716182-B2 | Liquid aqueous crop protection formulations | BASF SE (DE) | 2014-05-06 | — | — | US | disclosed |
| US-8703650-B2 | Liquid suspension concentrate formulations containing saflufenacil | BASF SE (DE) | 2014-04-22 | — | — | US | disclosed |
| US-20120302444-A1 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL | BASF SE (DE) | 2012-11-29 | — | — | US | disclosed |
| EP-0077974-B2 | PROCESS FOR PRODUCING PROPYLENE GLYCOL MONOACETATE | KURARAY CO., LTD. (JP) | 1993-04-07 | — | — | EP | disclosed |
| CN-1019496-B | PROPOLENE POLYMER AND THEIR PRODUETION | SHELL OIL CO (US) | 1992-12-16 | — | — | CN | disclosed |
| CN-1010780-B | IMPROVING CATALYST PRODUCTIVITY IN POLYMERIZATION OF OLEFINS | UNION CARBIDE CORP (US) | 1990-12-12 | — | — | CN | disclosed |
| CN-1033813-A | Propene polymer and production thereof | SHELL OIL CO (US) | 1989-07-12 | — | — | CN | disclosed |
| US-4723036-A | HYDROFORMYLATION OF VINYL ACETATE, RHODIUM COMPEX AND PHOSPINE, SOLVENT EXTRACTION, HYDROGENATION, RANEY CATALYSTS | KURARAY COMPANY, LTD. (JP) | 1988-02-02 | — | — | US | disclosed |
| EP-0160969-A2 | Cephem compounds | Takeda Chemical Industries, Ltd. (JP) | 1985-11-13 | — | — | EP | disclosed |
| EP-0077974-B1 | PROCESS FOR PRODUCING PROPYLENE GLYCOL MONOACETATE | KURARAY CO., LTD. (JP) | 1985-09-25 | — | — | EP | disclosed |
| US-4500727-A | HYDROFORMYLATION; EXTRACTION; SEPARATION; OXIDATION; REACTION WITH METHANOL | KURARAY CO., LTD. (JP) | 1985-02-19 | — | — | US | disclosed |
| EP-0077974-A1 | Process for producing propylene glycol monoacetate | KURARAY CO., LTD. (JP) | 1983-05-04 | — | — | EP | disclosed |
| US-4246405-A | Method for preparation of β-lactam compound | FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1981-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170258795-A1 | FUSED PYRIMIDINES AS INHIBITORS OF P97 COMPLEX | PSMG3, PSME1, PSMB1 | ALDH1A1 2774/4885LMNA 1854/4885TSHR 4697/4885 |
| US-20120302444-A1 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL | SCD5, FFAR3, FFAR2 | ALDH1A1 977/4885LMNA 402/4885TSHR 2738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.